article thumbnail

Antimicrobial Stewardship in the United kingdom: Perspective From A Pharmacist At A Bone & Joint Hospital

IDStewardship

At the same time, there were multiple competing priorities, such as managing the bone infection caseloads, implementing changes to departmental IPC practice, vaccination programmes and new COVID-19 treatments. Like all AMS teams, trying to be agile and respond to this change has been an enormous challenge.

Hospitals 147
article thumbnail

NK cell immunotherapy: what’s next in clinical development?

European Pharmaceutical Review

The progress of the RNA technology and tumour specific vaccination will be also key to increase adaptive immunity against the tumour but also as it participates to the activation of the innate immunity through RNA sensing. In 2007, he became in charge for business development and in 2017, also became responsible of the portfolio strategy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A history of AstraZeneca

pharmaphorum

In 2007, AstraZeneca’s pipeline was the subject of much speculation, as the company began to face increasing pressure from generics as many of its key drugs began to reach patent expiry. In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2

Vaccines 116
article thumbnail

First continuous mRNA manufacturing platform to be developed

European Pharmaceutical Review

This $85 million programme ran between 2007 and 2019. Moderna’s mRNA vaccine manufacturing centre begins construction … The post First continuous mRNA manufacturing platform to be developed appeared first on European Pharmaceutical Review.

FDA 98
article thumbnail

Record number of health firms feature in UK top 100 private tech list

pharmaphorum

There are pharma companies on the list, including Kymab , which at number 87 is working with the Bill & Melinda Gates Foundation to test several potential vaccines. Also on the list is Faculty, which at number 33 provides accurate and timely information used by decision-makers in the NHS and the government.

article thumbnail

A Pharmacist’s Path Towards Developing Medical Strategy for Field-Based Teams

Pharmacy Is Right For Me

Brown is the National Field Director for Janssen Infectious Diseases & Vaccines. I have been in the pharmaceutical industry since 2007 and have been in various roles involving medical affairs and research and development. Please describe your novel practice setting. What makes your career path unique?

Vaccines 130
article thumbnail

Tagamet for Warts and Shingles!

The People's Pharmacy

One study found that more than 80 percent of treated patients had a significant response, though it did take six to eight weeks to see improvement ( Archives of Dermatology , June, 1996 ; Annals of Pharmacotherapy , July, 2007 ). The dose was 30 mg/kg/day. To calculate weight in kg, divide the weight in pounds by 2.2.